Skull Fractures
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Simulation Training in Emergency Department Imaging 2
Screening Emotions in Adolescents at the Hospital for mTBI
PMCF Study on CranioFix®2 System Used for the Fixation of Craniotomized Bone Flaps and Fractures
Assess the Clinical Effectiveness in AI Prioritising CT Heads
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Evolution of Facial Trauma During COVID Containment Measures
Association Between Craniofacial Fractures and Brain Injuries: Diagnostic and Therapeutic Considerations